Home › Pituitary Dwarfism › District of Columbia
Pituitary Dwarfism clinical trials in District of Columbia
4 studies for Pituitary Dwarfism are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
- Lumos Pharma Investigational Site, Washington D.C.
RecruitingPhase 3
Ages 3 to 11 · All sexes · Updated Sep 4, 2026 · NCT06948214Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
RecruitingPhase 3
Ages 21 to 55 · All sexes · Updated Jul 9, 2026 · NCT04867317A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
- Ascendis Investigational Site, Washington D.C.
RecruitingObservational study
All ages · All sexes · Updated Apr 21, 2026 · NCT05820672A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
- Ascendis Investigational Site, Washington D.C.
RecruitingObservational study
Ages 1 to 18 · All sexes · Updated Feb 4, 2026 · NCT05775523From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.